Selective Wealth Management, Inc. Capricor Therapeutics, Inc. Transaction History

Selective Wealth Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 28, 2022	SELL	$2.89 - $4.51 $616,997 - $962,857	-213,494 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$2.83 - $5.68 $604,188 - $1.21 Million	213,494 New	213,494 $732,000

140

12.3M

4.99M

5.52M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $152M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.